Inflamm-aging: autoimmunity, and the immune-risk phenotype

Area of Science:

• Immunology
• Gerontology

Background:

• Immunosenescence, the aging of the immune system, is characterized by declining cell-mediated immunity, particularly T cell function.
• A paradoxical increase in autoantibody frequency occurs alongside immune decline, potentially linked to accumulated cells or environmental factors.
• This leads to the concept of an immune-risk phenotype (IRP), defined by specific cytokine profiles, impaired cell death, and altered T cell subsets.

Purpose of the Study:

• To define the immune-risk phenotype (IRP) as a bridge between basic immunology and clinical applications.
• To explore the factors contributing to IRP, including cytokine profiles, activation-induced cell death, and T cell subset shifts.
• To lay the groundwork for strategies aimed at immune reconstitution in the elderly.

Main Methods:

• The study defines immunosenescence and the immune-risk phenotype (IRP) based on existing literature and postulates.
• It discusses the role of T cell function, autoantibody production, and cytokine profiles in IRP.
• The concept integrates defects in activation-induced cell death and shifts in T cell subsets.

Main Results:

• Aging immune systems show reduced T cell-mediated immunity.
• Autoantibody frequency increases with age, potentially leading to autoimmune diseases.
• The immune-risk phenotype (IRP) is characterized by distinct cytokine profiles and cellular defects.

Conclusions:

• The immune-risk phenotype (IRP) offers a framework for understanding age-related immune dysfunction.
• Understanding IRP is crucial for developing interventions to improve immune function in older adults.
• Further research into IRP can guide strategies for immune reconstitution and enhance healthspan.